To better understand how the glycolytic shift induced by DUSP6 knockdown impacts tumor cell behavior, we revisited our previously conducted functional assays and incorporated 2-DG, a well-established inhibitor of glucose metabolism, into the analyses. This evidence concerns the gene DUSP6 and neoplasm.